Apr 24, 2017 4:30 pm EDT Capricor Therapeutics to Report Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy
Mar 15, 2017 4:10 pm EDT Capricor Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Mar 07, 2017 8:00 am EST Capricor Therapeutics to Hold Fourth Quarter and Full Year 2016 Financial Results and Corporate Update Conference Call on Wednesday, March 15
Feb 07, 2017 7:00 am EST Capricor Therapeutics to Present at the 2017 BIO CEO and Investor Conference
Nov 21, 2016 7:00 am EST Capricor Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 10, 2016 4:07 pm EST Capricor Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 10, 2016 4:05 pm EST Capricor Therapeutics Announces Plans to Expand Clinical Development Program in Duchenne Muscular Dystrophy to Evaluate Peripheral and Respiratory Muscle Function
Nov 03, 2016 7:00 am EDT Capricor Therapeutics to Hold Third Quarter 2016 Business Update and Financial Results Conference Call and Webcast on Thursday, November 10 at 5:00 p.m. ET